Product/Composition:- | Docetaxel |
---|---|
Strength:- | 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL |
Form:- | injection |
Reference Brands:- | Taxotere®. |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Docetaxel is an intravenous chemotherapy drug used to treat cancers like breast cancer, NSCLC, prostate cancer, and more. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vials, it is marketed as Taxotere® in both the US and EU, providing key B2B opportunities in oncology.
Docetaxel is an intravenous chemotherapy agent used to treat a variety of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, and head and neck cancers. As a taxane, it works by inhibiting cell division, effectively preventing cancer cell proliferation. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vial strengths, Docetaxel is marketed under the brand name Taxotere® in both the US and EU. The drug offers significant B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications